ESC 365 - Do we really need aspirin?

ACVC Premium Access

Do we really need aspirin?

Session: Anti-thrombotic management in patients with acute coronary syndromes (ACS)

Topic: Thrombosis, Platelets, and Coagulation

Speaker: Professor R. Mehran (New York, US)

Event: ESC Acute CardioVascular Care 2022

Congress Presentation

Add to my library

About the speaker

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)

53 presentations

12 followers

4 more presentations in this session

The novel subcutaneously administered glycoprotein IIb/IIIa antagonist RUC-4 (Zalunfiban) did not cause thrombocytopenia in the phase 2a study of patients with ST-elevation myocardial infarction

Speaker: Mr S. Rikken (Nieuwegein, NL)

Antiplatelet pretreatment in NSTE-ACS: do we have the answer?

Speaker: Doctor P. Capranzano (Catania, IT)

Extended, standard or de-escalation antiplatelet therapy after ACS?

Speaker: Professor K. Huber (Vienna, AT)

Anti-thrombotic management in patients with acute coronary syndromes - discussion.

Access the full session

Anti-thrombotic management in patients with acute coronary syndromes (ACS)

Speakers: Professor R. Mehran, Mr S. Rikken, Doctor P. Capranzano, Professor K. Huber

About the event

ESC Acute CardioVascular Care 2022

18 March - 19 March 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources